MYCOF

Mydecine Innovations Group Inc. MYCOF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MYCOF GSAC LVTTF CHOOF AVCNF MRRCF RVVTF HAVLF TRUFF
6M -66.67 % 33.33 % 0.00 % 0.00 % 1.55 % -90.00 % -23.75 % -90.00 % 13.96 %
YTD -66.94 % 33.33 % 0.00 % 900.00 % -8.28 % -90.00 % 134.62 % -90.00 % -16.91 %
1Y -67.74 % 0.00 % 0.00 % 0.00 % -5.88 % -90.00 % 103.33 % 0.00 % -11.23 %
3Y -99.62 % -75.76 % -47.27 % -99.66 % -5.26 % 900.00 % -94.41 % -99.86 % -68.41 %
5Y -99.42 % -85.19 % -99.24 % -99.98 % -72.14 % -99.80 % -93.61 % -100.00 % -89.46 %
10Y -99.42 % -96.36 % -99.24 % -99.93 % -92.73 % -99.90 % -97.68 % -100.00 % -89.46 %
From the beginning -99.42 % -99.92 % -99.24 % -100.00 % -92.73 % -100.00 % -97.68 % -100.00 % -89.46 %

Dividend